Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 69097-209

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 69097-209). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (59017833 74a7 4af8 B04d 6128c57b46be 01)

Chemical structure diagram of the active ingredient emtricitabine, showing the molecule's atoms and bonds including nitrogen, fluorine, oxygen, and sulfur elements.*

FDA Label Image

Image (59017833 74a7 4af8 B04d 6128c57b46be 02)

Chemical structure diagram of Tenofovir Disoproxil Fumarate, showing molecular bonds and groups characteristic of its chemical composition.*

FDA Label Image

30 Tablets (59017833 74a7 4af8 B04d 6128c57b46be 03)

Label for Emtricitabine and Tenofovir Disoproxil Fumarate tablets, film coated, 200 mg/300 mg strength. The label is from Cipla USA Inc. and includes dosing, storage instructions, and packaging details for 30 tablets. The NDC is 69097-209-02, and it indicates the product is prescription only with a barcode visible on the right.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.